Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q2 2019 · 10-Q
Revenue$2.42M$2.42M−28.5% vs Q2 2018 Net Income-$217.98K-$217.98KN/M vs Q2 2018 EPS Diluted-$0.03-$0.03N/M vs Q2 2018 Operating Income-$226,547N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$260,526N/M Margins · derivedOperating margin-9.4%−16.6 pt vs Q2 2018
Net margin-9.0%−30.0 pt vs Q2 2018
ended Dec 31, 2018 · filed Feb 14, 2019 · 45 d after period end